Silver Book Fact

Total direct and indirect costs of stroke in the U.S. are projected to reach $140 billion by 2030. This represents a 238% change in direct costs compared to 2010, and a 73% change in indirect costs.

Heidenreich, PA, JG Trogdon, OA Khavjou, J Butler, K Dracup, MD Ezekowtiz, EA Finkelstein, Y Hong, SC Johnston, A Khera, DM Lloyd-Jones, SA Nelson, G Nichol, De Orenstein, PWF Wilson, YJ Woo; on behalf of the American Heart Association Advocacy Coordinati. Forecasting the Future of Cardiovascular Disease in the United States: A policy statement from the American Heart Association. Circ. 2011; published online DOI: 10.1161/CIR.0b013e31820a55f5. http://circ.ahajournals.org/cgi/content/abstract/CIR.0b013e31820a55f5v1

Reference

Title
Forecasting the Future of Cardiovascular Disease in the United States: A policy statement from the American Heart Association
Publication
Circ
Publication Date
2011
Authors
Heidenreich, PA, JG Trogdon, OA Khavjou, J Butler, K Dracup, MD Ezekowtiz, EA Finkelstein, Y Hong, SC Johnston, A Khera, DM Lloyd-Jones, SA Nelson, G Nichol, De Orenstein, PWF Wilson, YJ Woo; on behalf of the American Heart Association Advocacy Coordinati
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • Total hospital costs (inpatients, outpatients, and emergency department patients) projected for the year 2008 are estimated to be $140.1 billion. Cardiovascular disease costs more than any other diagnostic group.  
  • AFib patient hospital visits
    Individuals with atrial fibrillation (AF) are 4 times more likely to visit the hospital 3 or more times in the year following an AF diagnosis—compared to those without the disease.  
  • In 2008, cardiovascular disease accounted for 32.8% of all deaths in the U.S.–811,940, or 1 of every 3 deaths in the U.S.  
  • Medical service utilization in AFib
    Medical service utilization in persons with and without atrial fibrillation  
  • The direct medical costs and indirect costs in loss of productivity of heart disease and stroke in the U.S. was estimated at $315.4 billion in 2010.